Medications associated with Gaucher disease
Ingredients whose current FDA labeling lists an association with gaucher disease, extracted from manufacturer submissions via NIH DailyMed.
Label-linked ingredients
Eliglustat
CERDELGA is indicated for the long-term treatment of adult patients with Gaucher disease type 1 (GD1) who are ...
Imiglucerase
CEREZYME is indicated for the treatment of non-central nervous system (CNS) manifestations of Type 1 or Type 3...
Taliglucerase Alfa
ELELYSO is indicated for the treatment of patients 4 years of age and older with a confirmed diagnosis of Type...
Velaglucerase Alfa
VPRIV is indicated for long-term enzyme replacement therapy (ERT) for patients with type 1 Gaucher disease....
Lab tests that investigate gaucher disease
CBC with Differential
Measures red blood cells, white blood cells, and platelets to help evaluate overall health and detect disorder...
Comprehensive Metabolic Panel (CMP)
Measures 14 substances in the blood to assess kidney and liver function, electrolyte balance, and blood sugar ...
Urinalysis
Examines urine content to help detect urinary tract infections, kidney disease, and diabetes....
Frequently Asked Questions
What medications are used for gaucher disease?
The medications listed above are associated with gaucher disease in current FDA-approved labeling as reported by manufacturers through NIH DailyMed. Only a qualified prescriber can determine appropriate treatment.
Do these medications cure gaucher disease?
This site does not provide treatment advice. The list reflects labeled associations, not recommendations. Discuss options, risks, and benefits with your healthcare provider.
Medical disclaimer: Educational content only. Not medical advice or a treatment recommendation.